A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Aelis Farma, a France-based drug developer spun out of Inserm, has listed on Euronext Paris following a €25m ($28.1m) initial public offering. Aelis Farma’s shareholders include Inserm’s tech transfer office, Inserm Transfert Initiative, which had helped the spinout raise a total of $14m prior to the flotation. Dive Technologies, a US-based subsea robotics developer that…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.

Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).